Skip to main content

Day: September 22, 2025

NEO Battery Enters into LOI for Operational Battery Component Manufacturing Facility Lease and Announces Non-Brokered Private Placement Offering

TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) — NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery developer that enables longer-running, rapid-charging batteries for drones, robotics, and electronics, is pleased to announce that it has entered into a Letter of Intent (“LOI”) with a South Korean battery company to lease an operational, revenue-generating battery components manufacturing facility to initiate customized, high-performance battery production for the drone, unmanned aerial vehicle (UAV), robotics, electronics, automotive, and energy storage sectors. In connection, the Company intends to undertake a non-brokered private placement. Operational Battery Component Facility Lease Arrangement Under the terms of the LOI, NEO intends to enter into a long-term lease arrangement...

Continue reading

MBX Biosciences Announces Proposed Public Offering

CARMEL, Ind., Sept. 22, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed underwritten public offering of 10,000,000 shares of its common stock. Furthermore, MBX Biosciences intends to grant the underwriters a 30-day option to purchase from MBX Biosciences up to an additional 1,500,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. The public offering price has not yet been determined. The proposed offering is subject to market and other conditions,...

Continue reading

Firefly Aerospace Announces Second Quarter 2025 Financial Results After Historic IPO

Company increased backlog to $1.3 billion by end of July and bolstered balance sheet; FAA cleared Alpha for return to flightFirefly Aerospace rang the Bell at the Nasdaq MarketSite on August 7, 2025. CEDAR PARK, Texas, Sept. 22, 2025 (GLOBE NEWSWIRE) — Firefly Aerospace (Nasdaq: FLY), a market leading space and defense technology company, today issued financial results for the second quarter ended June 30, 2025. “Firefly’s historic IPO last month reflects the bold culture of our generational company, which delivers on the most challenging missions in space,” said Firefly Aerospace CEO Jason Kim. “We’re pleased to announce our initial quarterly results as a public company, reflecting the steady progress across our launch and spacecraft products.” Second Quarter 2025 HighlightsCEO Jason Kim testified before Congress on the success...

Continue reading

Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update

Interim Clinical Study Results for Cohort 1 of the BB-301 Phase 1b/2a Treatment Study Anticipated in Q4 2025 Enrollment of the First Subject into Cohort 2 of the BB-301 Phase 1b/2a Treatment Study Expected in Q4 2025 HAYWARD, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today announced financial results for its full year ended June 30, 2025. The Company has filed its annual report on Form 10-K with the U.S. Securities and Exchange Commission. “We remain incredibly thankful for our continued close collaboration with families, clinical researchers, and healthcare providers as we...

Continue reading

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination

Semnur’s shares of common stock and warrants are expected to continue to trade on the OTC Markets under the ticker symbols “SMNR” and “SMNRW”, respectively. Scilex (together with its affiliates) owns approximately 87.5% of Semnur common stock post Business CombinationPALO ALTO, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX) , an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its majority-owned subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”), and Denali Capital Acquisition Corp (“Denali”), a special purpose acquisition company, announced the closing of their previously...

Continue reading

KBC Group: KBC’s reaction to the Bloomberg article “Belgium’s KBC is exploring a potential deal for ABN Amro”

Referring to KBC Group’s earlier and repeated statements about its strategy, we remain committed to pursuing financially sound and sustainable growth. We are continuously monitoring the market to identify opportunities that strengthen our unique digital-first bank-insurance group. Currently, we are only studying a potential acquisition of the State-backed Belgian Insurance company, Ethias NV.Attachment20250922-pb-reaction-kbc-en

Continue reading

Asante Announces Listing on TSX Venture Exchange

VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) — Asante Gold Corporation (TSXV: ASE | GSE: ASG | FRANKFURT:1A9 | OTCQX: ASGOF) (“Asante” or the “Company“) is pleased to announce that its common shares (the “Common Shares“) will commence trading on the TSX Venture Exchange (the “TSXV“) effective at markets open on Wednesday, September 24, 2025. In connection with the Company’s listing on the TSXV, the Common Shares will no longer trade on the CSE and will be voluntarily delisted from the CSE effective as of close of markets on Tuesday, September 23, 2025. Shareholders are not required to exchange their direct registration system advices or share certificates, or take any other action in connection with the TSXV listing. The Company will remain a “reporting...

Continue reading

Employers prepare for disruptive and transformative health plan changes, WTW survey finds

Initiatives are broad, encompassing vendor management, program and reimbursement reviews, alternative plan designs, increased governance and more NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) — Companies plan to evaluate disruptive changes to their healthcare plans as the cost of healthcare in the U.S. rises to the highest point in over two decades, according to a new survey by WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company. The 2025 Best Practices in Healthcare Survey finds that U.S. employers project their healthcare costs, before plan changes, will increase by 9.1% in 2026, compared with 8.1% in 2025 and 7.0% in 2024. The trend after plan changes is 8.0%, 7.0% and 6.0%, respectively. Cost pressures have prompted one in three employers to consider making significant changes to their healthcare programs...

Continue reading

Quorum Information Technologies Announces Definitive Agreement to be Acquired by Valsoft Corporation in an All-Cash Transaction

All outstanding common shares of Quorum to be acquired for $0.80 per share in an all-cash transaction The Board of Quorum has unanimously approved the transaction and recommends shareholders vote in favour Officers, directors and certain shareholders holding 50% of outstanding common shares have agreed to vote in support of the transaction CALGARY, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) — Quorum Information Technologies Inc. (TSX-V: QIS) (“Quorum” or the “Company”), a North American SaaS Software and Services company providing essential enterprise solutions that automotive dealerships and Original Equipment Manufacturers (“OEMs”) rely on for their operations, is pleased to announce that it has entered into an arrangement agreement dated September 22, 2025 (the “Arrangement Agreement”) pursuant to which an affiliate (the “Purchaser”)...

Continue reading

Altitude Sports Extends Partnership with TEGNA Stations 9NEWS, My20 for Second Consecutive Year, Bringing 20 Nuggets Games, 20 Avalanche Games Free to Denver Fans

Altitude+ Continues to Offer Locally Broadcast Games DENVER and TYSONS, Va., Sept. 22, 2025 (GLOBE NEWSWIRE) — Kroenke Sports & Entertainment (KSE) today announced the extension of its successful agreement with TEGNA (NYSE: TGNA) to broadcast 20 Denver Nuggets games and 20 Colorado Avalanche games for free over-the-air on Denver’s 9NEWS (KUSA-TV) and My20 (KTVD-TV). “We couldn’t be more excited to bring this fan-first partnership with TEGNA back for another year,” said Kevin Demoff, president of team and media operations, KSE. “Last season’s overwhelming community response to this partnership reinforced our commitment to ensuring that the fans who support the Nuggets and Avs can cheer on their favorite teams even when they can’t be with us at Ball Arena.” The broadcast agreement with TEGNA Denver stations 9NEWS and My20 will...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.